Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, LAM RESEARCH CORP insiders sold a net $111.6M of stock across 223 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
56 earlier Form 4 trades (code P or S) here by this insider (56 sales), the last on Sep 9, 2026.
The trade is 2.9% of the 1,075,966 shares held after it.
No other insider sold within 30 days.
1,706 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO ARCHER TIMOTHY sold about $7.1M of LRCX under a 10b5-1 plan on Oct 23, 2026; 1,706 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 7, 2025.
The trade is 45.5% of the 20,995 shares held after it.
3 other insiders sold within 30 days.
1,706 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Mayer Bethany sold about $3.0M of LRCX on Sep 9, 2026; 3 other insiders sold within 30 days and 1,706 funds added in the latest 13F quarter.
55 earlier Form 4 trades (code P or S) here by this insider (55 sales), the last on Aug 6, 2026.
The trade is 2.8% of the 1,075,966 shares held after it.
3 other insiders sold within 30 days.
1,706 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO ARCHER TIMOTHY sold about $9.6M of LRCX under a 10b5-1 plan on Sep 9, 2026; 3 other insiders sold within 30 days and 1,706 funds added in the latest 13F quarter.
6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Feb 20, 2025.
The trade is 9.7% of the 205,546 shares held after it.
3 other insiders sold within 30 days.
1,706 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Senior Vice President Varadarajan Seshasayee sold about $5.8M of LRCX under a 10b5-1 plan on Sep 2, 2026; 3 other insiders sold within 30 days and 1,706 funds added in the latest 13F quarter.
6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Feb 20, 2025.
The trade is 6.0% of the 205,546 shares held after it.
3 other insiders sold within 30 days.
1,706 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Senior Vice President Varadarajan Seshasayee sold about $3.6M of LRCX under a 10b5-1 plan on Sep 2, 2026; 3 other insiders sold within 30 days and 1,706 funds added in the latest 13F quarter.
223 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
LRCX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
ARCHER TIMOTHY
Filed 2026-10-23
$7.1M
ARCHER TIMOTHY
Filed 2026-09-09
$9.6M
BETHANY MAYER
Filed 2026-09-09
$3.0M
Varadarajan Seshasayee
Filed 2026-09-02
$17.4M
Harter Ava
Filed 2026-08-31
$1.5M
LRCX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
MIDAS SPECIAL OPPORTUNITIES
$5.2M position · as of 2026-06-30
17.7%
NORTHQUEST CAPITAL FUND INC
$1.7M position · as of 2026-06-30
14.7%
Neiman Large Cap Value Fund
$5.8M position · as of 2026-06-30
11.5%
Baron Technology ETF
$18.1M position · as of 2026-06-30
8.8%
Invesco Global Equity Portfolio
$96.4M position · as of 2026-06-30
8.5%
MassMutual Global Fund
$12.2M position · as of 2026-06-30
8.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Timothy M. Archer
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$40.4M
$320.6M
$8.8M
+533%
+330%
2024
$28.3M
$14.7M
$8.4M
+61%
+79%
2023
$30.1M
$71.7M
$6.9M
+75%
+75%
2022
$18.3M
$35.5M
$4.7M
-1%
+11%
2021
$16.9M
$10.3M
$4.2M
-28%
-15%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $111.6M sold by insiders over 180 days, 1,706 funds added last quarter, 2 House member(s) bought in 12 months, disclosed weeks after the trade, $47.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$26.1B
four quarters, 2025-09-29 to 2026-09-27
Revenue, TTM LRCX
FY Jun 2026
$23.2B
FY Jun 2025
$18.4B
FY Jun 2024
$14.9B
FY Jun 2023
$17.4B
FY Jun 2022
$17.2B
Sep 2026
$8.2B
Jun 2026
$6.7B
Mar 2026
$5.8B
Dec 2025
$5.3B
Sep 2025
$5.3B
Jun 2025
$5.2B
Mar 2025
$4.7B
Dec 2024
$4.4B
At each fiscal year end
Single quarter
Net margin, TTM
+32.3%
net income over revenue, 2025-09-29 to 2026-09-27
Net margin, TTM LRCX
FY Jun 2026
+31.3%
FY Jun 2025
+29.1%
FY Jun 2024
+25.7%
FY Jun 2023
+25.9%
FY Jun 2022
+26.7%
Sep 2026
+33.5%
Jun 2026
+33.9%
Mar 2026
+31.2%
Dec 2025
+29.8%
Sep 2025
+29.5%
Jun 2025
+33.3%
Mar 2025
+28.2%
Dec 2024
+27.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
$6.5B
operating cash flow minus capex, 2025-09-29 to 2026-09-27
Free cash flow, TTM LRCX
FY Jun 2026
$4.9B
FY Jun 2025
$5.4B
FY Jun 2024
$4.3B
FY Jun 2023
$4.7B
FY Jun 2022
$2.6B
Sep 2026
$3.2B
Jun 2026
$1.3B
Mar 2026
$809.8M
Dec 2025
$1.2B
Sep 2025
$1.6B
Jun 2025
$2.4B
Mar 2025
$1.0B
Dec 2024
$553.6M
At each fiscal year end
Single quarter
Debt to equity
0.27x
long-term 2026-09-27 plus current 2026-06-28; equity 2026-09-27
Debt to equity LRCX
FY Jun 2026
0.30x
FY Jun 2025
0.45x
FY Jun 2024
0.58x
FY Jun 2023
0.60x
FY Jun 2022
0.79x
Sep 2026
0.27x
Jun 2026
0.30x
Mar 2026
0.42x
Dec 2025
0.44x
Sep 2025
0.44x
Jun 2025
0.45x
Mar 2025
0.44x
Dec 2024
0.57x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
2.03x
TTM operating cash flow over long-term 2026-09-27 plus current 2026-06-28
Cash flow to debt LRCX
FY Jun 2026
1.57x
FY Jun 2025
1.38x
FY Jun 2024
0.94x
FY Jun 2023
1.04x
FY Jun 2022
0.62x
Sep 2026
2.03x
Jun 2026
1.57x
Mar 2026
1.55x
Dec 2025
1.59x
Sep 2025
1.43x
Jun 2025
1.38x
Mar 2025
1.06x
Dec 2024
0.92x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+70.1%
TTM net income over average of 2025-09-28 and 2026-09-27
Return on equity LRCX
FY Jun 2026
+65.1%
FY Jun 2025
+58.2%
FY Jun 2024
+45.7%
FY Jun 2023
+62.3%
FY Jun 2022
+74.8%
Sep 2026
+70.1%
Jun 2026
+65.1%
Mar 2026
+66.8%
Dec 2025
+65.6%
Sep 2025
+62.3%
Jun 2025
+58.2%
Mar 2025
+53.1%
Dec 2024
+50.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+35.0%
TTM net income over average of 2025-09-28 and 2026-09-27
Return on assets LRCX
FY Jun 2026
+32.4%
FY Jun 2025
+26.7%
FY Jun 2024
+20.4%
FY Jun 2023
+25.1%
FY Jun 2022
+27.8%
Sep 2026
+35.0%
Jun 2026
+32.4%
Mar 2026
+32.9%
Dec 2025
+30.1%
Sep 2025
+28.0%
Jun 2025
+26.7%
Mar 2025
+24.4%
Dec 2024
+22.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+96.3%
operating income after a 13.0% effective tax rate, over long-term 2026-09-27 plus current 2026-06-28 plus average of 2025-09-28 and 2026-09-27 minus cash
Return on invested capital LRCX
FY Jun 2026
+81.0%
FY Jun 2025
+70.3%
FY Jun 2024
+48.3%
FY Jun 2023
+58.7%
FY Jun 2022
+66.8%
Sep 2026
+96.3%
Jun 2026
+81.0%
Mar 2026
+70.6%
Dec 2025
+76.6%
Sep 2025
+77.5%
Jun 2025
+70.3%
Mar 2025
+62.1%
Dec 2024
+53.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+56.4%
operating income (EBIT proxy) over average of 2025-09-28 and 2026-09-27 minus current liabilities
Return on capital employed LRCX
FY Jun 2026
+50.7%
FY Jun 2025
+40.4%
FY Jun 2024
+29.4%
FY Jun 2023
+38.0%
FY Jun 2022
+43.1%
Sep 2026
+56.4%
Jun 2026
+50.7%
Mar 2026
+49.5%
Dec 2025
+46.8%
Sep 2025
+44.0%
Jun 2025
+40.4%
Mar 2025
+37.3%
Dec 2024
+33.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
35.39x
close 2026-10-26 over four quarters of diluted EPS, 2025-09-29 to 2026-09-27
P/E, trailing LRCX
FY Jun 2026
65.81x
FY Jun 2025
23.42x
FY Jun 2024
36.72x
FY Jun 2023
18.50x
FY Jun 2022
1.38x
Sep 2026
46.98x
Jun 2026
65.81x
Mar 2026
39.96x
Dec 2025
36.56x
Sep 2025
28.33x
Jun 2025
23.42x
Mar 2025
20.23x
Dec 2024
22.31x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$293.0B
market value at close 2026-10-26 on 2026-10-20 shares, plus long-term 2026-09-27 plus current 2026-06-28, minus cash 2026-09-27
Enterprise value LRCX
FY Jun 2026
$472.2B
FY Jun 2025
$122.4B
FY Jun 2024
$13.0B
FY Jun 2023
$7.8B
FY Jun 2022
$7.7B
Sep 2026
$390.7B
Jun 2026
$472.2B
Mar 2026
$263.7B
Dec 2025
$222.0B
Sep 2025
$160.2B
Jun 2025
$122.4B
Mar 2025
$92.0B
Dec 2024
$93.8B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield LRCX
FY Jun 2026
+1.0%
FY Jun 2025
+4.4%
FY Jun 2024
+30.6%
FY Jun 2023
+57.2%
FY Jun 2022
+40.9%
Sep 2026
+1.7%
Jun 2026
+1.0%
Mar 2026
+2.3%
Dec 2025
+2.8%
Sep 2025
+3.4%
Jun 2025
+4.4%
Mar 2025
+4.1%
Dec 2024
+4.3%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.74x
P/E over trailing EPS growth of 48%: four quarters to 2026-09-27 against the four to 2025-09-28
PEG, trailing LRCX
FY Jun 2026
1.70x
FY Jun 2025
0.54x
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
0.06x
Sep 2026
0.98x
Jun 2026
1.70x
Mar 2026
0.84x
Dec 2025
0.76x
Sep 2025
0.61x
Jun 2025
0.54x
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
LRCX ranks highest on profitability (97th percentile) and institutional and government (76th), and lowest on insider conviction (7th), among Semiconductors & Electronics peers.
Profitability
97
Inputs
Return on equity+70.1% · 97 pct, sector of 154
Return on assets+35.0% · 98 pct, sector of 171
Return on invested capital+96.3% · 96 pct, sector of 56
Return on capital employed+56.4% · 98 pct, sector of 155
Financial health
67
Inputs
Debt to equity0.27x · 48 pct, sector of 152
Cash flow to debt2.03x · 87 pct, sector of 136
Growth
53
Inputs
Revenue growth, YoY+26.0% · 68 pct, sector of 194
Backlog growth, YoY-3.9% · 38 pct, sector of 51
Insider conviction
7
Inputs
Net Form 4 buying (codes P and S), 180d-$76.0M · 14 pct, sector of 146
Insider buyers, 180d0 · 0 pct, sector of 150
Institutional and government
76
Inputs
Funds adding, latest quarter1,706 · 96 pct, sector of 184
Congress net buyers, 365d1 · 59 pct, sector of 40
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$810K · 73 pct, sector of 53
Risk and compliance
42
Inputs
Short interest, % of float+2.3% · 73 pct, sector of 220
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+27.6% · 11 pct, sector of 152
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
LRCX filings, in plain words
Are LAM Research insiders buying or selling LRCX?
In the 180 days to 2026-10-28, LAM Research insiders were net sellers, a net $111.6M across purchases and sales reported on Form 4, by 7 sellers.
Have members of Congress traded LRCX?
Yes. In the year to 2026-10-28, 2 House members disclosed buying LRCX and 1 House member disclosed selling it; the latest on record is a sale by David J. Taylor dated 2026-06-05.
Are there planned insider sales of LRCX?
Yes. 6 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $47.6M of stock; the latest, by ARCHER TIMOTHY, was filed 2026-10-23.
Read the full summary
In the 180 days to 2026-10-28, LAM Research insiders were net sellers of LRCX, a net $111.6M across purchases and sales reported on Form 4 by 7 sellers. 11% of the 55 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 2 members of Congress disclosed buying LRCX and 1 member disclosed selling it; the latest on record is a sale by David J. Taylor dated 2026-06-05. Insiders filed 6 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $47.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.